BAVARIAN’S FIRST YELLOW FEVER VACCINATION SITE

IN MUNICH

The practice Dr. Frühwein is one of the first yellow fever vaccination sites in Europe and the first one in Munich.

The World Health Organization (WHO) only approves institutions with special qualifications for yellow fever vaccination.
This is due to the danger posed by the yellow fever disease, the previously very difficult handling of the vaccine and the endeavor to ensure the highest possible level of safety for the affected persons. The executing authorities in Germany are the respective ministries of the federal states.

Already in 1947 Dr. Friedrich Frühwein, the founder of the existing practice Dr. Frühwein and Partner, received the permit to vaccinate against yellow fever.

Thus he justified the practice specialty for:

  • Travel vaccinations of any kind
  • Travel medicine including malaria prevention
  • Tropical medicine with tropical preliminary and follow-up tropical examinations

Yellow fever or black vomiting is a viral infectious disease, transmitted by mosquitoes in tropical and subtropical regions of Africa and South America. Fever, nausea and pain resolve after a few days. In severe cases, it can lead to sometimes fatal liver damage, jaundice or a blood clotting disorder. According to WHO estimates, about 200,000 people develop yellow fever each year, with the disease being fatal in 15% of cases. 90% of the infections occur on the African continent.

Since there is no known therapy for yellow fever, the vaccination for yellow fever, developed by Max Theiler is all the more important. It is considered to be very safe and effective. The live vaccine strain 17D was isolated by Theiler from a deceased in Ghana in 1937 and has since been propagated in incubated chicken eggs. In rare cases, the vaccine causes flu-like symptoms.

According to the WHO, the vaccine may only be administered to small children after nine months. Adults over the age of 60 are at increased risk of serious side effects, which is why their constitution must first be checked. A risk-benefit analysis must also be carried out for pregnant women; yellow fever vaccination should not be given for thymus diseases.

Behavior and Tips
for Traveling

Patient
Information

Recipe
Order

Online
Booking